Bellerophon Therapeutics Probability of Future Stock Price Finishing Over 0.065

BLPHDelisted Stock  USD 0.07  0.04  35.00%   
Bellerophon Therapeutics' future price is the expected price of Bellerophon Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Bellerophon Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
  
Please specify Bellerophon Therapeutics' target price for which you would like Bellerophon Therapeutics odds to be computed.

Bellerophon Therapeutics Target Price Odds to finish over 0.065

The tendency of Bellerophon Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.07 90 days 0.07 
close to 99
Based on a normal probability distribution, the odds of Bellerophon Therapeutics to move above the current price in 90 days from now is close to 99 (This Bellerophon Therapeutics probability density function shows the probability of Bellerophon Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.25 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bellerophon Therapeutics will likely underperform. Additionally Bellerophon Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Bellerophon Therapeutics Price Density   
       Price  

Predictive Modules for Bellerophon Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bellerophon Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bellerophon Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.060.070.07
Details
Intrinsic
Valuation
LowRealHigh
0.060.060.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bellerophon Therapeutics. Your research has to be compared to or analyzed against Bellerophon Therapeutics' peers to derive any actionable benefits. When done correctly, Bellerophon Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bellerophon Therapeutics.

Bellerophon Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bellerophon Therapeutics is not an exception. The market had few large corrections towards the Bellerophon Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bellerophon Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bellerophon Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-2.64
β
Beta against NYSE Composite1.25
σ
Overall volatility
0.12
Ir
Information ratio -0.23

Bellerophon Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bellerophon Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bellerophon Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Bellerophon Therapeutics is not yet fully synchronised with the market data
Bellerophon Therapeutics has some characteristics of a very speculative penny stock
Bellerophon Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (19.83 M) with profit before overhead, payroll, taxes, and interest of 0.
Bellerophon Therapeutics currently holds about 16.33 M in cash with (17.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Bellerophon Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bellerophon Stock often depends not only on the future outlook of the current and potential Bellerophon Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bellerophon Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding9.6 M
Cash And Short Term Investments6.9 M

Bellerophon Therapeutics Technical Analysis

Bellerophon Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Bellerophon Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bellerophon Therapeutics. In general, you should focus on analyzing Bellerophon Stock price patterns and their correlations with different microeconomic environments and drivers.

Bellerophon Therapeutics Predictive Forecast Models

Bellerophon Therapeutics' time-series forecasting models is one of many Bellerophon Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bellerophon Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Bellerophon Therapeutics

Checking the ongoing alerts about Bellerophon Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bellerophon Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bellerophon Therapeutics is not yet fully synchronised with the market data
Bellerophon Therapeutics has some characteristics of a very speculative penny stock
Bellerophon Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (19.83 M) with profit before overhead, payroll, taxes, and interest of 0.
Bellerophon Therapeutics currently holds about 16.33 M in cash with (17.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Bellerophon Stock

If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets